探索精选案例、学术成果及更多技术资源
晶泰科技与 Acerand Therapeutics 合作以高精度物理模型及人工智能加速抗肿瘤先导化合物的优化
晶泰科技与开拓药业就抗肿瘤单克隆抗体药物研发达成合作
Uncertainty Distribution of Crystal Structure Prediction
晶泰科技与 Sedec Therapeutics 达成合作, 推进抗自身免疫疾病的创新性小分子药物发现
中奥生物与晶泰科技合作,运用 AI 从头设计蛋白药物
聚焦原始创新,晶泰科技与勤浩医药联合开发新型小分子抗肿瘤药物
晶泰科技联手溪砾科技,打造基于 AI+DEL 技术的靶向 RNA 小分子药物发现平台
PhoreMost 与晶泰科技合作,6个月攻克“不可成药”靶点
Virtual Coformer Screening by a Combined Machine Learning and Physics-based Approach
A Cloud Computing Platform for Scalable Relative and Absolute Binding Free Energy Prediction: New Opportunities and Challenges for Drug Discovery
Scaffold Hopping Transformations Using Auxiliary Restraints for Calculating Accurate Relative Binding Free Energies
Selecting a Stable Solid Form of Remdesivir Using Microcrystal Electron Diffraction and Crystal Structure Prediction

晶泰搜索

Avibactam Tomilopil Form 1: A Rare Pharmaceutical Mesophase
揭开多肽结晶密码:AI与计算化学驱动的智能结晶策略
创新方法 | MicroED突破ASD体系中微量晶体快速鉴定瓶颈